close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

RDY

13.4

+1.06%↑

NEOG

10.21

+0.1%↑

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Gesloten

SectorGezondheidszorg

33.01 -1.29

Strong Buy

Prijsupdate 30 jan 2026, 20:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

32.72

Max

33.1

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

-35M

Verkoop

70M

71M

Winstmarge

-49.028

Werknemers

143

EBITDA

66M

-34M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+35.15% upside

Dividenden

By Dow Jones

Volgende Winsten

25 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1B

3.2B

Vorige openingsprijs

34.3

Vorige sluitingsprijs

33.01

Nieuwssentiment

By Acuity

33%

67%

68 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 jan 2026, 20:14 UTC

Acquisities, Fusies, Overnames

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

DJ

Lezen

31 jan 2026, 18:48 UTC

Acquisities, Fusies, Overnames

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- Update

DJ

Lezen

31 jan 2026, 16:40 UTC

Winsten

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

DJ

Lezen

31 jan 2026, 09:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:47 UTC

Acquisities, Fusies, Overnames

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

DJ

Lezen

30 jan 2026, 23:41 UTC

Marktinformatie

Deckers Outdoor Seen as Undervalued -- Market Talk

DJ

Lezen

30 jan 2026, 23:12 UTC

Acquisities, Fusies, Overnames

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

DJ

Lezen

30 jan 2026, 22:20 UTC

Winsten

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

DJ

Lezen

30 jan 2026, 22:10 UTC

Marktinformatie

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

DJ

Lezen

30 jan 2026, 21:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

30 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

30 jan 2026, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

30 jan 2026, 21:42 UTC

Winsten

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

DJ

Lezen

30 jan 2026, 21:36 UTC

Winsten

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

DJ

Lezen

30 jan 2026, 21:33 UTC

Winsten

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

DJ

Lezen

30 jan 2026, 20:42 UTC

Winsten

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

DJ

Lezen

30 jan 2026, 20:37 UTC

Acquisities, Fusies, Overnames

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

DJ

Lezen

30 jan 2026, 20:20 UTC

Marktinformatie

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

DJ

Lezen

30 jan 2026, 20:13 UTC

Marktinformatie

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

DJ

Lezen

30 jan 2026, 19:52 UTC

Winsten

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

DJ

Lezen

30 jan 2026, 19:29 UTC

Marktinformatie
Winsten

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

DJ

Lezen

30 jan 2026, 19:09 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

30 jan 2026, 19:09 UTC

Marktinformatie

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

35.15% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 44.6 USD  35.15%

Hoogste 61 USD

Laagste 34 USD

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Gebaseerd op 13 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

68 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

JNJ

Johnson and Johnson

227.38

↑ +0.01%

ISRG

Intuitive Surgical Inc

503.63

↓-0.84%

ABT

Abbott Laboratories

109.23

↑ +3.01%

RDY

Dr Reddy's Laboratories Ltd-ADR

13.4

↑ +1.06%

NEOG

Neogen Corp

10.21

↑ +0.1%
help-icon Live chat